Tuesday, January 29, 2019 6:07:31 AM
Vancouver, B.C. and Boston, MA, January 23, 2018 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leader in the development and commercialization of advanced medical imaging technologies,
announced today management will present an update on the Company’s business at NobleConXV, Noble Capital Markets’ Fifteenth Annual Investor Conference, on Tuesday, January 29, 2019, at 12:00 p.m. Eastern Time at the W Hotel in Fort Lauderdale, FL.
A webcast of the presentation will be available the following day on the Company’s website at imaginmedical.com/ in the ‘Investors’ section, and will be archived for 90 days.
https://imaginmedical.com/wp-content/uploads/2019/01/Press-Release-1-23-19-Nobles-Conference.pdf
/////AMG
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM